Log in to your Inderes Free account to see all free content on this page.
Stenocare
1.08 DKK
-7.73 %
Less than 1K followers
STENO
First North Denmark
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Stenocare
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1 | 1.5 | 4.8 | 0.9 | 1.7 | 1.9 | 2.6 | 7.0 |
| EBITDA | -3.9 | -15.1 | -24.2 | -1.8 | 0.0 | 0.1 | 0.0 | -1.7 |
| EBIT | -4.8 | -21.4 | -33.1 | -1.8 | 0.0 | 0.0 | -0.0 | -1.8 |
| EBIT-% | -426.8 % | -1,435.6 % | -695.2 % | -213.2 % | 0.1 % | 2.2 % | -0.2 % | -25.3 % |
| Profit before taxes | -5.0 | -21.7 | -34.6 | -2.0 | -0.1 | -0.1 | -0.1 | -2.4 |
| Net income | -4.7 | -22.3 | -34.5 | -2.0 | -0.1 | -0.1 | -0.1 | -2.4 |
Login required
This content is only available for logged in users